Healthcare Distribution Alliance – Patients Move Us.
Share Print



Results: 111 Articles found.
  • HDA Statement on Energy and Commerce Committee Report Regarding Opioid Distribution in West Virginia
    December 19, 2018

    On the release of the Energy and Commerce Committee’s review of opioid distribution in West Virginia, the Healthcare Distribution Alliance (HDA) released the following statement.

  • HDA Statement on New York Opioid Stewardship Act Ruling
    December 19, 2018

    Following U.S. District Court Judge Katherine Polk Failla’s ruling today that New York’s Opioid Stewardship Act is unconstitutional, the Healthcare Distribution Alliance (HDA) issued the following statement.

  • HDA Research Foundation Specialty Pharmaceutical Analysis Highlights Distributor Efficiencies Amid Evolving Market Dynamics
    December 18, 2018

    Data published by the HDA Research Foundation reveal the changing market dynamics of the nearly $200 billion specialty pharmaceutical supply chain segment — and the important role HDA-member specialty pharmaceutical distributors play within it. The 2018 Specialty Pharmaceutical Distribution: Facts, Figures and Trends publication is based on an annual survey of HDA-member specialty distributors with sales greater than $1 billion for the 2017 (or most recently completed) fiscal year, and includes secondary data from leading healthcare organizations, such as IQVIA.

  • HDA Statement in Response to 60 Minutes
    December 18, 2018

    “The latest episode of 60 Minutes perpetuates a number of myths around the opioid epidemic and does a disservice to any effort to truly understand and address its root causes — notably, the shift in medical practice to treat pain more aggressively and the role of illegal drugs in most overdose deaths.

  • HDA Statement to 60 Minutes
    December 14, 2018

    “While HDA cannot speak to the specifics of the litigation, it defies common sense to single out distributors for the opioid crisis. As logistics experts, distributors do not manufacture, promote or prescribe opioids, influence clinical decision-making or in any way drive demand for the product. Distributors deliver medicines prescribed by a licensed physician and ordered by a licensed pharmacy.

Website design and development by, inc
© 2018 Healthcare Distribution Alliance. All rights reserved.
HDA: M | C | D | NF | P | O365